Clinical Trials Browser

Active not recruiting × Metastatic Hormone Sensitive Prostate Cancer × Clear all

NCT04076059 2026-02-06

China ARCHES

Phase 3 Active not recruiting

180 enrolled 24 charts

Metastatic Hormone Sensitive Prostate Cancer